FE
52
2
GOOGL
72
5
AMGN
57
2
BDX
54
7
MAC
51
4
GOOG
89
2
IVZ
38
2
EIX
56
3
HBI
25
4
ADI
61
4
XRX
48
3
STI
58
20
COST
66
5
GIS
61
3
CI
52
-14
AAP
29
2
PSA
35
-8
OMC
65
7
RRC
65
3
NWSA
67
2
FE
52
2
GOOGL
72
5
AMGN
57
2
BDX
54
7
MAC
51
4
GOOG
89
2
IVZ
38
2
EIX
56
3
HBI
25
4
ADI
61
4
XRX
48
3
STI
58
20
COST
66
5
GIS
61
3
CI
52
-14
AAP
29
2
PSA
35
-8
OMC
65
7
RRC
65
3
NWSA
67
2
Financhill
Back

Ascendis Pharma A/S 10K Form

Sell
33

ASND
Ascendis Pharma A/S

Last Price:
137.19
Seasonality Move:
2.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASND News And Ratings

See the #1 stock for the next 7 days that we like better than ASND

ASND Financial Statistics

Sales & Book Value

Annual Sales: $288.75M
Cash Flow: $-43.27M
Price / Cash Flow: 0
Annual Sales: $-2.84
Price / Book: 0

Profitability

EPS (TTM): -9.27610
Net Income (TTM): $-521.73M
Gross Margin: $240.69M
Return on Equity: -880.05%
Return on Assets: -52.65%

Ascendis Pharma A/S Earnings Forecast

Key Ascendis Pharma A/S Financial Ratios

  • The Gross Profit Margin over the past 5 years for ASND is 83.36%.
  • The Selling, General & Administrative Expenses for ASND have been equal to 99.13% of Gross Profit Margin.
  • The Research & Development expenses have been 155.02% of Revenue.
  • The Interest Expense is -9.15% of Operating Income.
  • The Net Earning history of ASND is -180.51% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

Ascendis Pharma A/S Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASND
CUSIP: 04351P
Website: ascendispharma.com

Debt

Debt-to-Equity Ratio: -3.74
Current Ratio: 3.56
Quick Ratio: 2.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASND Technical Analysis vs Fundamental Analysis

Sell
33
Ascendis Pharma A/S (ASND) is a Sell

Is Ascendis Pharma A/S a Buy or a Sell?